In Vivo Gene Delivery to the Pulmonary Circulation in Rats: Transgene Distribution and Vascular Inflammatory Response

David M. Rodman, Hong San, Robert Simari, Dominique Stephan, Felix Tanner, Zhiyong Yang, Gary J. Nabel, Elizabeth G. Nabel

Research output: Contribution to journalArticle

Abstract

Although gene delivery to the pulmonary circulation has both experimental and therapeutic potential, the delivery methods, distribution of transgene, and subsequent inflammatory response have been poorly characterized to date. To address these issues, we utilized a 0.76-mm OD (outside diameter) end hole catheter inserted into the internal jugular vein of adult Sprague-Dawley rats, directing the tip into a pulmonary capillary wedge position. We then compared infusion of polycationic lipid:DNA complexes to replication-defective adenovirus with respect to magnitude and distribution of transgene expression using either chloramphenicol acetyltransferase (CAT) or human placental alkaline phosphatase (hpAP) reporter genes. Both lipid:DNA and adenovirus resulted in detectable transgene expression, though maximum lung CAT activity using lipid (γAP-DLRIE/DOPE) was approximately 2% of maximum activity using adenovirus (Ad-CAT). Further characterization of expression after transfection with 108 pfu (plaque forming units) of Ad-CAT demonstrated persistence of transgene for at least 14 days (lung CAT activity 27% of maximum). Alkaline phosphatase staining demonstrated that both large and small pulmonary arteries as well as the alveolar wall expressed transgene. Although little inflammatory response was detected in conduit arteries, a predominantly mononuclear cell infiltrate surrounded small pulmonary arteries as well as the alveolar spaces in transfected areas of lung. We conclude that percutaneous catheter-mediated gene delivery to the pulmonary circulation in rats using non-viral and viral vectors is feasible. Although an inflammatory response to first generation replication-defective adenovirus was detected, it appeared to be largely restricted to the distal pulmonary circulation and airspace. This technique should prove useful for investigations requiring overexpression of novel genes in the pulmonary artery wall, and could ultimately be used to develop gene-based therapies for pulmonary vascular diseases.

Original languageEnglish (US)
Pages (from-to)640-649
Number of pages10
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume16
Issue number6
StatePublished - 1997
Externally publishedYes

Fingerprint

Chloramphenicol O-Acetyltransferase
Pulmonary Circulation
Transgenes
Blood Vessels
Rats
Adenoviridae
Genes
Pulmonary Artery
Lung
Catheters
Lipids
DNA
Jugular Veins
Vascular Diseases
Reporter Genes
Genetic Therapy
Lung Diseases
Transfection
Alkaline Phosphatase
Sprague Dawley Rats

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Pulmonary and Respiratory Medicine

Cite this

In Vivo Gene Delivery to the Pulmonary Circulation in Rats : Transgene Distribution and Vascular Inflammatory Response. / Rodman, David M.; San, Hong; Simari, Robert; Stephan, Dominique; Tanner, Felix; Yang, Zhiyong; Nabel, Gary J.; Nabel, Elizabeth G.

In: American Journal of Respiratory Cell and Molecular Biology, Vol. 16, No. 6, 1997, p. 640-649.

Research output: Contribution to journalArticle

Rodman, DM, San, H, Simari, R, Stephan, D, Tanner, F, Yang, Z, Nabel, GJ & Nabel, EG 1997, 'In Vivo Gene Delivery to the Pulmonary Circulation in Rats: Transgene Distribution and Vascular Inflammatory Response', American Journal of Respiratory Cell and Molecular Biology, vol. 16, no. 6, pp. 640-649.
Rodman, David M. ; San, Hong ; Simari, Robert ; Stephan, Dominique ; Tanner, Felix ; Yang, Zhiyong ; Nabel, Gary J. ; Nabel, Elizabeth G. / In Vivo Gene Delivery to the Pulmonary Circulation in Rats : Transgene Distribution and Vascular Inflammatory Response. In: American Journal of Respiratory Cell and Molecular Biology. 1997 ; Vol. 16, No. 6. pp. 640-649.
@article{e39de6b3ccee4ab4af2958a2e12af883,
title = "In Vivo Gene Delivery to the Pulmonary Circulation in Rats: Transgene Distribution and Vascular Inflammatory Response",
abstract = "Although gene delivery to the pulmonary circulation has both experimental and therapeutic potential, the delivery methods, distribution of transgene, and subsequent inflammatory response have been poorly characterized to date. To address these issues, we utilized a 0.76-mm OD (outside diameter) end hole catheter inserted into the internal jugular vein of adult Sprague-Dawley rats, directing the tip into a pulmonary capillary wedge position. We then compared infusion of polycationic lipid:DNA complexes to replication-defective adenovirus with respect to magnitude and distribution of transgene expression using either chloramphenicol acetyltransferase (CAT) or human placental alkaline phosphatase (hpAP) reporter genes. Both lipid:DNA and adenovirus resulted in detectable transgene expression, though maximum lung CAT activity using lipid (γAP-DLRIE/DOPE) was approximately 2{\%} of maximum activity using adenovirus (Ad-CAT). Further characterization of expression after transfection with 108 pfu (plaque forming units) of Ad-CAT demonstrated persistence of transgene for at least 14 days (lung CAT activity 27{\%} of maximum). Alkaline phosphatase staining demonstrated that both large and small pulmonary arteries as well as the alveolar wall expressed transgene. Although little inflammatory response was detected in conduit arteries, a predominantly mononuclear cell infiltrate surrounded small pulmonary arteries as well as the alveolar spaces in transfected areas of lung. We conclude that percutaneous catheter-mediated gene delivery to the pulmonary circulation in rats using non-viral and viral vectors is feasible. Although an inflammatory response to first generation replication-defective adenovirus was detected, it appeared to be largely restricted to the distal pulmonary circulation and airspace. This technique should prove useful for investigations requiring overexpression of novel genes in the pulmonary artery wall, and could ultimately be used to develop gene-based therapies for pulmonary vascular diseases.",
author = "Rodman, {David M.} and Hong San and Robert Simari and Dominique Stephan and Felix Tanner and Zhiyong Yang and Nabel, {Gary J.} and Nabel, {Elizabeth G.}",
year = "1997",
language = "English (US)",
volume = "16",
pages = "640--649",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - In Vivo Gene Delivery to the Pulmonary Circulation in Rats

T2 - Transgene Distribution and Vascular Inflammatory Response

AU - Rodman, David M.

AU - San, Hong

AU - Simari, Robert

AU - Stephan, Dominique

AU - Tanner, Felix

AU - Yang, Zhiyong

AU - Nabel, Gary J.

AU - Nabel, Elizabeth G.

PY - 1997

Y1 - 1997

N2 - Although gene delivery to the pulmonary circulation has both experimental and therapeutic potential, the delivery methods, distribution of transgene, and subsequent inflammatory response have been poorly characterized to date. To address these issues, we utilized a 0.76-mm OD (outside diameter) end hole catheter inserted into the internal jugular vein of adult Sprague-Dawley rats, directing the tip into a pulmonary capillary wedge position. We then compared infusion of polycationic lipid:DNA complexes to replication-defective adenovirus with respect to magnitude and distribution of transgene expression using either chloramphenicol acetyltransferase (CAT) or human placental alkaline phosphatase (hpAP) reporter genes. Both lipid:DNA and adenovirus resulted in detectable transgene expression, though maximum lung CAT activity using lipid (γAP-DLRIE/DOPE) was approximately 2% of maximum activity using adenovirus (Ad-CAT). Further characterization of expression after transfection with 108 pfu (plaque forming units) of Ad-CAT demonstrated persistence of transgene for at least 14 days (lung CAT activity 27% of maximum). Alkaline phosphatase staining demonstrated that both large and small pulmonary arteries as well as the alveolar wall expressed transgene. Although little inflammatory response was detected in conduit arteries, a predominantly mononuclear cell infiltrate surrounded small pulmonary arteries as well as the alveolar spaces in transfected areas of lung. We conclude that percutaneous catheter-mediated gene delivery to the pulmonary circulation in rats using non-viral and viral vectors is feasible. Although an inflammatory response to first generation replication-defective adenovirus was detected, it appeared to be largely restricted to the distal pulmonary circulation and airspace. This technique should prove useful for investigations requiring overexpression of novel genes in the pulmonary artery wall, and could ultimately be used to develop gene-based therapies for pulmonary vascular diseases.

AB - Although gene delivery to the pulmonary circulation has both experimental and therapeutic potential, the delivery methods, distribution of transgene, and subsequent inflammatory response have been poorly characterized to date. To address these issues, we utilized a 0.76-mm OD (outside diameter) end hole catheter inserted into the internal jugular vein of adult Sprague-Dawley rats, directing the tip into a pulmonary capillary wedge position. We then compared infusion of polycationic lipid:DNA complexes to replication-defective adenovirus with respect to magnitude and distribution of transgene expression using either chloramphenicol acetyltransferase (CAT) or human placental alkaline phosphatase (hpAP) reporter genes. Both lipid:DNA and adenovirus resulted in detectable transgene expression, though maximum lung CAT activity using lipid (γAP-DLRIE/DOPE) was approximately 2% of maximum activity using adenovirus (Ad-CAT). Further characterization of expression after transfection with 108 pfu (plaque forming units) of Ad-CAT demonstrated persistence of transgene for at least 14 days (lung CAT activity 27% of maximum). Alkaline phosphatase staining demonstrated that both large and small pulmonary arteries as well as the alveolar wall expressed transgene. Although little inflammatory response was detected in conduit arteries, a predominantly mononuclear cell infiltrate surrounded small pulmonary arteries as well as the alveolar spaces in transfected areas of lung. We conclude that percutaneous catheter-mediated gene delivery to the pulmonary circulation in rats using non-viral and viral vectors is feasible. Although an inflammatory response to first generation replication-defective adenovirus was detected, it appeared to be largely restricted to the distal pulmonary circulation and airspace. This technique should prove useful for investigations requiring overexpression of novel genes in the pulmonary artery wall, and could ultimately be used to develop gene-based therapies for pulmonary vascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=0031154714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031154714&partnerID=8YFLogxK

M3 - Article

C2 - 9191465

AN - SCOPUS:0031154714

VL - 16

SP - 640

EP - 649

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 6

ER -